Cargando…

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia

BACKGROUND: Leukotriene receptor antagonists (LTRAs) alleviate Alzheimer’s disease (AD) pathology and improve cognition in animal models; however, clinical evidence is limited. This study aimed to explore the associations between the use of LTRAs (montelukast or zafirlukast) and cognitive performanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Lisa Y., Ouk, Michael, Wu, Che-Yuan, Rabin, Jennifer S., Lanctôt, Krista L., Herrmann, Nathan, Black, Sandra E., Edwards, Jodi D., Swardfager, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418104/ https://www.ncbi.nlm.nih.gov/pubmed/34479635 http://dx.doi.org/10.1186/s13195-021-00892-7

Ejemplares similares

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
por: Wu, Che‐Yuan, et al.
Publicado: (2022)

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021)

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
por: Wu, Che‐Yuan, et al.
Publicado: (2020)

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease
por: Cogo‐Moreira, Hugo, et al.
Publicado: (2023)

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
por: Bawa, Kritleen K., et al.
Publicado: (2020)

Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment?
por: Intzandt, Brittany, et al.
Publicado: (2015)

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
por: Gold, Allison B, et al.
Publicado: (2011)

Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular Cognitive Impairment
por: Isaacs-Trepanier, Cameron, et al.
Publicado: (2020)

Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment
por: Cloutier, Simon, et al.
Publicado: (2015)

Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment
por: Sussams, Rebecca, et al.
Publicado: (2020)

Screening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia Screening Questionnaire
por: Lee, Sun-Ju, et al.
Publicado: (2018)

Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline
por: Hestad, Knut, et al.
Publicado: (2020)

Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time
por: Cogo-Moreira, Hugo, et al.
Publicado: (2020)

COPING WITH COGNITIVE DECLINE AMONG OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT OR MILD DEMENTIA: A SCOPING REVIEW
por: Cho, Youngmin, et al.
Publicado: (2022)

Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment
por: Suridjan, Ivonne, et al.
Publicado: (2017)

Rates of Screening for Breast, Colorectal, and Cervical Cancers in Older People With Cognitive Impairment or Dementia: A Meta-Analysis
por: Law, Marcus, et al.
Publicado: (2018)

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis
por: Pieper, Nina T, et al.
Publicado: (2020)

Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline
por: van Maurik, Ingrid S., et al.
Publicado: (2020)

Blood pressure in dementia, mild cognitive impairment, and subjective cognitive decline related to time of death
por: Hestad, Knut Asbjørn, et al.
Publicado: (2021)

Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia
por: Morgan, Catherine A., et al.
Publicado: (2021)

Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?
por: O'Caoimh, Rónán, et al.
Publicado: (2013)

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020)

Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer’s Dementia in Persons With Subjective Cognitive Decline
por: Ahn, Sangwoo, et al.
Publicado: (2020)

Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment
por: Koch, Manja, et al.
Publicado: (2019)

Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2023)

Microstructural brain changes track cognitive decline in mild cognitive impairment
por: Reas, Emilie T., et al.
Publicado: (2018)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms
por: McGirr, Alexander, et al.
Publicado: (2022)

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
por: Azami, Hamed, et al.
Publicado: (2023)

Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating Scale
por: Yang, Yu-Wan, et al.
Publicado: (2021)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
por: Bauer, Corinna M., et al.
Publicado: (2018)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Cerebellar Cortex and Cerebellar White Matter Volume in Normal Cognition, Mild Cognitive Impairment, and Dementia
por: Zdanovskis, Nauris, et al.
Publicado: (2021)

Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia
por: Hattori, Yorito, et al.
Publicado: (2023)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
por: Behl, Pearl, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ef62qf8cjimjt0k80gd3bnd92